Off-label, but on-target: Use of regadenoson with exercise
- 1 April 2013
- journal article
- editorial
- Published by Elsevier BV in Journal of Nuclear Cardiology
- Vol. 20 (2), 179-181
- https://doi.org/10.1007/s12350-012-9643-5
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- A strategy of symptom-limited exercise with regadenoson-as-needed for stress myocardial perfusion imaging: A randomized controlled trialJournal of Nuclear Cardiology, 2013
- Ten Common Questions (and Their Answers) About Off-label Drug UseMayo Clinic Proceedings, 2012
- What Does Off-label Prescribing Really Mean?Archives of Internal Medicine, 2012
- Safety and feasibility of regadenoson use for suboptimal heart rate response during symptom-limited standard Bruce exercise stress testJournal of Nuclear Cardiology, 2012
- Lessons from regadenoson and low-level treadmill/regadenoson myocardial perfusion imaging: Initial clinical experience in 1263 patientsJournal of Nuclear Cardiology, 2010
- Shifting Terrain in the Regulation of Off-Label Promotion of PharmaceuticalsThe New England Journal of Medicine, 2009
- The RegEx trial: a randomized, double-blind, placebo- and active-controlled pilot study combining regadenoson, a selective A2A adenosine agonist, with low-level exercise, in patients undergoing myocardial perfusion imagingJournal of Nuclear Cardiology, 2009
- Adenosine versus regadenoson comparative evaluation in myocardial perfusion imaging: Results of the ADVANCE phase 3 multicenter international trialJournal of Nuclear Cardiology, 2007
- Impact of an abbreviated adenosine protocol incorporating adjunctive treadmill exercise on adverse effects and image quality in patients undergoing stress myocardial perfusion imagingJournal of Nuclear Cardiology, 2000
- Impact of limited treadmill exercise on adenosine Tc-99m sestamibi single-photon emission computed tomographic myocardial perfusion imaging in coronary artery diseaseThe American Journal of Cardiology, 1999